Although there was a trend for faster development of Gr2 OM with concurrent cetuximab compared to RT‐alone group, the difference did not reach statistical significance ( P = 0.086).
← all excerpts
Feasibility of optimizing intensity-modulated radiation therapy plans based on measured mucosal dose adjacent to dental fillings and toxicity outcomes.
1
0.0860
0.0860